Responses
Abstracts Accepted for Publication
Crystal diseases, metabolic bone diseases and bone diseases other than osteoporosis
AB0817 Analysis of Interleukin-1β Inhibitor (Canakinumab) Impact on Endothelial Dysfunction
Compose a Response to This Article
Other responses
No responses have been published for this article.